5 Best MedTech Companies to Watch 2025
The Silicon Review
| Company | Management | Description |
|---|---|---|
| NATROX® Wound Care natroxwoundcare.com |
Nancy Stahulak, VP Global Marketing & U.S. Sales |
NATROX® Wound Care is recognized for advancing chronic wound management through its innovative continuous topical oxygen therapy (cTOT) devices. The company has been distinguished for delivering clinically validated, patient-centered solutions that improve healing outcomes, reduce complications, and enhance quality of life for individuals with hard-to-heal wounds. |
| Absolute Medical, Inc. absolutemedical.com |
Shane Fitzpatrick, CEO |
Absolute Medical, Inc. is dedicated to delivering compassionate care through advanced compression products and insurance advocacy. Garment specialists and billing experts work collaboratively to ensure accessible, patient-centered lymphedema management nationwide. |
| Pathway Medtech pathwaymedtech.com |
Arthur Deptala, CEO |
Pathway Medtech is recognized for delivering fully integrated medical device development and manufacturing solutions. Design, regulatory, and production services are coordinated to ensure efficient, high-quality, and FDA-compliant product commercialization for clients nationwide. |
| Inlightenment getinlightened.com |
Shelli Pavone, President & Co-Founder |
Inlightened is recognized for bridging healthcare knowledge gaps through a curated network of experts. Its platform is leveraged to streamline access to vetted professionals, ensuring insights are translated into actionable innovation. |
| Elitac Wearables elitacwearables.com |
Merijn Klarenbeek, CEO |
Elitac Wearables is recognized for advancing MedTech innovation through wearable devices that seamlessly integrate electronics and textiles under the leadership of Chief Executive Officer Merijn Klarenbeek. The company has been distinguished for creating meaningful solutions that improve health, safety, and performance on a global scale. |
MOST VIEWED ARTICLES
RECOMMENDED NEWS
TOP NEWS
YOU MAY ALSO LIKE
_2025-10-02_10-21-48.webp)
